Join us at EuroPCR 2017!
With the next edition taking place 16-19 May in Paris, take a look at why the Programme of this World-Leading Course in Interventional Cardiovascular Medicine continues to attract 11,000+ participants year after year. The video includes comments gathered from participants at last year’s Course, and will make you keen to find out more about EuroPCR! Registrations are open!EuroPCR 2017 Register
PCR Peripheral 2016: guarantee a safe and efficient treatment of your patient
Course Director T. Zeller invites you to join the dedicated Course on peripheral interventions to learn everything step-by-step from pre-interventional diagnostic to closure.
Get a Glimpse of PCR China Chengdu Valves: watch the opening ceremony video
Thank you so much to everyone who attended the 2nd edition of this Course, jointly organised by PCR, CIT (China Interventional Therapeutics), and the West China Hospital of Sichuan University, focusing on transcatheteraortic valve implantation (TAVI).
EuroPCR 2017: tips for a simple innovation submission
Follow these simple guidelines to submit your innovative technologies by 10 February 2017. Take a chance to present your best work at EuroPCR 2017.Submit your innovative technologies
EuroPCR 2017: tips for a simple abstract submission
Follow these simple guidelines to submit your abstracts by 14 January 2017. Take a chance to present your best work at EuroPCR 2017.
EuroPCR 2017: submit your images
EuroPCR Course Director J. Fajadet invites you to share images illustrating your daily practice challenges at the upcoming World-Leading Course in Interventional Cardiovascular Medicine. Your submissions are essential for the community: take a chance to be part of the Programme!Submit your images
MASTER: Safety and efficacy of biodegradable polymer DES in management of patients with acute STEMI
From EuroPCR 2016
M. Valdes introduces the MASTER study showing us just how BMS were put to the test. Taking a close look at the treatment of patients with acute STEMI, MASTER compares DES with bioresorbable polymer with bare metal stents. And the outcomes? At 4 and 6 months, in a population representative of daily practice, the results were in favour of the DES.Learn more about the details of this study – efficacy and favourable short-term safety, late lost, target vessel failure.
BRS in long lesions - Optimising implantations results
By beginning with the question of what in fact constitutes a long lesion, M. Haude and N.E.J. West lead us through an illuminating discussion of bioresorbable scaffolds and why, with increasing experience they pose a valid alternative to the former dependence on a “full metal jacket” philosophy.What are the procedural aspects that differ with BRS that are essential in their good deployment? What are the specific pitfalls or structural concerns about these devices when used in long lesions? And what about DAPT? Learn more on where we stand today with the clinical uses of BRS…
Ischaemic stroke intervention - Why the acute stroke network is important
With more than 15 million strokes occurring worldwide, and the number of neuro-interventionalists still limited – what role can interventional cardiologists play?Join neurosurgeon L. N. Hopkins as he speaks with A. Cremonesi and B. Reimers on this challenging question. Learn about the similarities in the treatment of acute myocardial infarction and acute ischaemic stroke; of the 5 recent trials that demonstrate the benefits of endovascular interventions over thrombolysis alone, and learn why the time has come for cardiologists to join with their colleagues in neuroradiology to respond effectively to this healthcare challenge. Can the precept “time is muscle” translate to “time is brain”?Learn more today…
LAA closure with imaging guidance
From the very beginning of LAA closure, imaging plays a central role which is touched on in this wide-ranging discussion led by O. Muller with S. Berti and F. Hellig. To understand the complex anatomy of the left atrial appendage we need to effectively use imaging, even before the intervention begins.Again, we depend on imaging to see if there is thrombus present, or to plan our clinical strategy or afterwards to judge the efficacy of our intervention – but what are the minimum imaging modalities we need to in order to safely perform LAA closure? What imaging technologies are employed today, and are there new ones emerging? How do we integrate the different imaging technologies into our clinical approach during closure?